V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013828 | 160019621 | 1.79 | 103.5 | Palliative (P) | null | null | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100122744 |
| 160013847 | 160019622 | 1.79 | 60.1 | Palliative (P) | 2018-08-08 | 2018-08-15 | Trabectedin | 02 | N | TRABECTEDIN | 100955049 |
| 160013859 | 160019623 | 1.68 | 64.3 | Palliative (P) | 2019-12-15 | 2019-12-16 | Trabectedin | 02 | N | TRABECTEDIN | 100379628 |
| 160013860 | 160019624 | 1.5 | 91 | null | 2017-10-28 | 2017-11-16 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101519657 |
| 160013863 | 160019625 | 1.73 | 55 | null | 2020-04-25 | 2020-05-01 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101715121 |
| 160013872 | 160019626 | 1.88 | 98.8 | null | 2019-08-12 | 2019-08-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101755754 |
| 160013913 | 160019628 | 1.73 | 90.9 | null | 2019-09-02 | 2019-09-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101348740 |
| 160013914 | 160019629 | 1.82 | 66.4 | Curative (C) | 2021-02-09 | 2021-02-22 | Trabectedin | 02 | N | TRABECTEDIN | 100485889 |
| 160013917 | 160019630 | 1.68 | 78.6 | null | 2018-03-18 | 2018-04-08 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 100696840 |
| 160013918 | 160019631 | 1.77 | 108.6 | null | 2021-09-18 | 2021-12-09 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100311164 |
| 160013933 | 160019632 | 1.59 | 87 | Palliative (P) | 2020-07-26 | 2020-07-28 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100821598 |
| 160013935 | 160019633 | 1.67 | 56 | Palliative (P) | 2018-02-23 | 2018-02-27 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101632894 |
| 160013944 | 160019634 | 1.6 | 86.4 | null | 2021-07-23 | 2021-07-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100224226 |
| 160013951 | 160019635 | 1.61 | 56.6 | Palliative (P) | 2020-02-02 | 2020-02-02 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101619753 |
| 160013977 | 160019637 | 1.54 | 45.6 | Palliative (P) | 2017-07-09 | 2017-07-09 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100169898 |
| 160014019 | 160019638 | 1.85 | null | Palliative (P) | 2015-08-21 | 2017-05-27 | DOXORUBICIN | N | N | DOXORUBICIN | 101111338 |
| 160014021 | 160019639 | 1.67 | 17.2 | Palliative (P) | 2019-11-12 | 2019-11-26 | Trabectedin | 02 | N | TRABECTEDIN | 100186641 |
| 160014037 | 160019640 | 1.73 | 71.8 | Palliative (P) | 2019-07-14 | 2019-07-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100243025 |
| 160014064 | 160019641 | 1.85 | 91.4 | Palliative (P) | 2018-12-09 | 2018-12-23 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101296044 |
| 160014087 | 160019642 | 1.73 | 60.5 | Palliative (P) | 2018-08-06 | 2018-08-06 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101088330 |
| 160014138 | 160019643 | 1.6 | 72.75 | null | 2017-01-27 | 2017-01-29 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100667969 |
| 160014174 | 160019645 | 1.6 | 59.4 | null | 2016-08-03 | 2016-12-20 | VINORELBINE | 02 | null | VINORELBINE | 101034093 |
| 160014201 | 160019646 | 1.52 | 50.6 | null | null | 2021-03-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100414099 |
| 160014217 | 160019647 | 1.6 | 67.2 | null | 2021-02-06 | 2021-02-10 | DOXORUBICIN | null | null | VINORELBINE | 101109654 |
| 160014240 | 160019648 | 1.53 | 73.5 | null | 2019-03-28 | 2019-04-04 | DOXORUBICIN | null | null | DOXORUBICIN | 101075444 |
| 160014265 | 160019649 | 1.73 | 87.1 | null | 2021-05-22 | 2021-09-03 | Trabectedin | 02 | null | TRABECTEDIN | 101288697 |
| 160014271 | 160019650 | 1.43 | 81.6 | Palliative (P) | 2019-10-21 | 2019-10-21 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 100692512 |
| 160014281 | 160019651 | 1.68 | 62.3 | Palliative (P) | 2021-05-08 | 2021-05-12 | VINORELBINE | 02 | N | VINORELBINE | 100240352 |
| 160014282 | 160019652 | 1.9 | 85 | null | 2017-08-06 | 2017-08-06 | Bevacizumab 15mg/kg | 02 | N | CARBOPLATIN | 100985017 |
| 160014283 | 160019653 | 1.8 | 88.6 | Palliative (P) | 2020-07-24 | 2020-07-24 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101271848 |
| 160014287 | 160019654 | 1.64 | 65 | Neo-adjuvant (N) | 2019-11-29 | 2019-12-24 | Bevacizumab | 02 | N | BEVACIZUMAB | 101229864 |
| 160014289 | 160019655 | 1.86 | 86.3 | null | null | 2019-05-21 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100788150 |
| 160014302 | 160019656 | 1.72 | 59.8 | null | null | 2021-01-26 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100095647 |
| 160014322 | 160019657 | 1.83 | 92 | null | 2020-01-27 | 2020-01-27 | Bevacizumab | 02 | null | CARBOPLATIN | 100655596 |
| 160014323 | 160019658 | 1.83 | 59.6 | null | 2018-04-12 | 2018-04-18 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100826169 |
| 160014329 | 160019659 | 1.88 | 76.9 | Palliative (P) | 2016-08-09 | 2017-01-28 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 100995212 |
| 160014343 | 160019660 | 1.57 | 79.8 | Palliative (P) | null | 2020-10-21 | PACLITAXEL | 02 | N | PACLITAXEL | 100057058 |
| 160014350 | 160019661 | 0 | 95 | Palliative (P) | 2020-12-30 | 2020-12-30 | Bevacizumab 7.5mg/kg | N | N | CARBOPLATIN + GEMCITABINE | 100135632 |
| 160014353 | 160019662 | null | 53.7 | null | 2020-04-18 | 2020-05-09 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100373638 |
| 160014354 | 160019663 | 1.73 | 88.1 | null | 2018-08-23 | 2018-08-30 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101316183 |
| 160014373 | 160019664 | 1.72 | 88.9 | 03 | 2019-05-12 | 2019-05-21 | PACLITAXEL | 02 | N | PACLITAXEL | 101243440 |
| 160014387 | 160019665 | 1.5 | 65 | Palliative (P) | 2020-02-02 | 2020-02-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101118890 |
| 160014399 | 160019666 | 1.65 | 75.5 | null | 2022-03-28 | 2022-04-19 | Bevacizumab 7.5mg/kg | 02 | null | DOCETAXEL + GEMCITABINE | 100308590 |
| 160014405 | 160019667 | 1.78 | 69.4 | Palliative (P) | 2018-03-14 | 2018-04-04 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101068634 |
| 160014452 | 160019668 | 1.68 | 90 | Neo-adjuvant (N) | 2020-08-19 | 2020-11-02 | Bevacizumab | 02 | N | BEVACIZUMAB | 101791412 |
| 160014461 | 160019669 | 1.56 | 72.9 | null | 2016-08-09 | 2016-09-05 | Bevacizumab | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101530149 |
| 160014474 | 160019670 | 1.69 | 86.2 | Neo-adjuvant (N) | 2021-04-16 | 2021-04-30 | Bevacizumab | N | N | CISPLATIN + PEMETREXED | 100567955 |
| 160014494 | 160019671 | 1.5 | 90.8 | Palliative (P) | 2020-05-27 | 2020-06-26 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101349691 |
| 160014497 | 160019672 | 1.83 | 80 | Palliative (P) | 2021-04-01 | 2021-04-07 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100551067 |
| 160014513 | 160019673 | 1.77 | 89 | null | 2019-06-23 | 2019-12-15 | Bevacizumab 15mg/kg | 02 | null | PACLITAXEL | 100533218 |